The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk ...

Amplitude (NASDAQ:AMPL – Get Free Report) had its target price lifted by equities researchers at UBS Group from $10.00 to $13.00 in a research report issued on Thursday,Benzinga reports. The brokerage ...

Full Year 2024 Results Key Financial Results Revenue: US$299.3m (up 8.3% from FY 2023).

Shares of Amplitude, Inc. (NASDAQ:AMPL – Get Free Report) hit a new 52-week high on Thursday after Morgan Stanley raised their price target on the stock from $11.00 to $13.00. Morgan Stanley currently ...

Amplitude, Inc. (AMPL) reports strong Q4 2024 results, highlighting 9% YoY revenue growth and new enterprise product launches.

Hello, everyone. Welcome to Amplitude's Fourth Quarter and Full Year 2024 Earnings Call. I'm John Streppa, Head of Investor Relations. Joining me today are Spenser Skates, CEO and Co-Founder of ...

Recurring Revenue was $312 million, up 11% year-over-year Remaining performance obligations of $308.6 million, up 29% year-over-year Fourth quarter revenue of $78.1 million, up 9% year-over-year ...

At Hydes, which remains untested by drilling, a modelled elongated magnetic pipe feature extends up to 1km vertically and ...

Russian astronomers have carried out spectroscopic and photometric observations of a cataclysmic variable designated Gaia ...

According to the paper, 29 out of the whole sample of pulsars reported in the study show some form of amplitude modulation ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...